top of page

Phase 1/2 rGBM


SonALAsense is now recruiting for a Phase 1/2 dose escalation and expansion study of sonodynamic therapy with SONALA-001 in combination with Exablate 4000 Type 2.0 MR-Guided
Focused Ultrasound (MRgFUS) in subjects with progressive or recurrent glioblastoma multiforme

For more details regarding the study design, please visit our listing:

This trial is now recruiting, Contact Us to learn more about eligibility.

bottom of page